Positives:
- organic growth of 9.7% is good
- looks like Vlad is attempting to get Hills/DAS back on track with profit expected from 2Q
- 1Q is generally the slowest with 2Q (tax/EOFY sales) and 4Q generally stronger so lets hope that remains the case
- gross margins improved on 2H despite higher interest rates so perhaps it does seem like the underlying business profitability is improving
Negatives
- Pbt margin still only 3.4% which is an improvement on 2H22, but still a long way from ~4% achieved before Exeed purchase (NZ margins have always been lower than Australia, but the Exeed purchase seems to be the tail wagging the dog.....the preso for FY22 indicated a retail presence and I wonder if that is what is hurting the entire business)
The lower quarterly dividend I hope signals a conservative approach rather than some indication of a slowdown (backorders have come down from 3Q last year so perhaps that leaves some uncertainty to a strong year?).
- Forums
- ASX - By Stock
- Ann: Q1 FY23 Market Update
DDR
dicker data limited
Add to My Watchlist
0.31%
!
$8.16

Positives: - organic growth of 9.7% is good - looks like Vlad is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.16 |
Change
-0.025(0.31%) |
Mkt cap ! $1.472B |
Open | High | Low | Value | Volume |
$8.22 | $8.23 | $8.06 | $2.410M | 296.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1143 | $8.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.16 | 1282 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 11452 | 8.140 |
3 | 809 | 8.130 |
6 | 2764 | 8.120 |
3 | 1054 | 8.110 |
5 | 6676 | 8.100 |
Price($) | Vol. | No. |
---|---|---|
8.160 | 1418 | 11 |
8.170 | 3823 | 9 |
8.180 | 4436 | 10 |
8.190 | 2224 | 6 |
8.200 | 8444 | 7 |
Last trade - 14.53pm 02/07/2025 (20 minute delay) ? |
Featured News
DDR (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online